Clients using Tirzepatide have reported accelerated fat loss, especially in the midsection, with better energy and fewer cravings
54 BMI as a metric of obesity has some limitations, such as not being able to differentiate between lean and fat mass, estimate the magnitude of visceral obesity and predict outcomes
Dosing schedule and titration rate play a significant role
Cytotherapy, 18 (8), 10371042
Yet videos featuring melanotan-II continue to appear, with measures taken to avoid the restrictions such as using generic hashtags like #tanning
In follow-up from the STEP 1 trial on semaglutide, average weight loss on semaglutide was 17.3% at week 68